Abstract

The blood‐brain barrier (BBB) is a physical and dynamic barrier that separates the central nervous system from the circulatory system in order to protect the brain from harmful endogenous and exogenous chemicals. The capillary endothelial cells that form the BBB are firmly sealed via tight junctions and express relatively high amounts of ATP‐binding cassette efflux transporters like P‐glycoprotein (P‐gp) and the breast cancer resistant protein (BCRP) to protect the brain from entry of potentially harmful chemicals. While protective to the brain under normal circumstances, this high level of expression of these proteins at the BBB are problematic when attempting to treat diseases of the brain like neurodegenerative diseases or brain cancers since P‐gp and BCRP impede entry of therapeutic drugs into the brain. Previously, we have computationally identified several drug‐like molecules that inhibit or modulate P‐gp and/or BCRP activities. The cell line, hCMEC/d3, was used in our studies as a model for the BBB. Using qPCR, we confirmed a higher level of expression of both P‐gp and BCRP in hCMEC/d3 cells when compared to non‐cancerous HFL‐1 cells. When hCMEC/d3 cells were treated with the P‐gp and BCRP inhibitors, accumulation of the P‐gp substrate rhodamine‐123 as well as the P‐gp and BCRP substrates, mitoxantrone and daunorubicin, was observed. We conclude that our newly discovered P‐gp and BCRP inhibitors may make good leads for the development of co‐therapeutics to inhibit and/or modulate the activity of P‐gp and BCRP in the BBB and facilitate therapeutic drug uptake through the BBB and into the brain.Support or Funding InformationThis work was supported by NIH NIGMS [R15GM094771‐02] to PVD and JGW, SMU University Research Council, the SMU Center for Drug Discovery, Design and Delivery, the Communities Foundation of Texas, and a private gift from Ms. Suzy Ruff of Dallas, Texas as well as the Hamilton Undergraduate Research Scholars Program, the SMU Summer Research and Undergraduate Research Assistantship Programs as well as the SMU Engaged Learning Program.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.